Sequoia Financial Advisors LLC Invests $254,000 in Kenvue Inc. (NYSE:KVUE)

Sequoia Financial Advisors LLC bought a new position in Kenvue Inc. (NYSE:KVUEFree Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 12,639 shares of the company’s stock, valued at approximately $254,000.

Several other institutional investors and hedge funds have also modified their holdings of the business. Kistler Tiffany Companies LLC acquired a new position in Kenvue during the 2nd quarter worth $26,000. Tamarack Advisers LP acquired a new position in Kenvue during the 2nd quarter worth $26,000. Clearstead Advisors LLC acquired a new position in Kenvue during the 3rd quarter worth $25,000. EverSource Wealth Advisors LLC acquired a new position in Kenvue during the 3rd quarter worth $28,000. Finally, AdvisorNet Financial Inc acquired a new position in Kenvue during the 3rd quarter worth $28,000. 11.33% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research analysts have issued reports on KVUE shares. Piper Sandler started coverage on Kenvue in a report on Friday, November 17th. They set a “neutral” rating and a $20.00 price objective on the stock. Royal Bank of Canada dropped their target price on shares of Kenvue from $25.00 to $24.00 and set an “outperform” rating for the company in a research report on Friday. UBS Group upped their target price on shares of Kenvue from $20.00 to $23.00 and gave the company a “neutral” rating in a research report on Tuesday, December 19th. Finally, JPMorgan Chase & Co. dropped their target price on shares of Kenvue from $25.00 to $24.00 and set an “overweight” rating for the company in a research report on Friday. Six research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $25.92.

Read Our Latest Analysis on KVUE

Kenvue Stock Performance

KVUE opened at $19.33 on Friday. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.78 and a current ratio of 1.14. Kenvue Inc. has a 12 month low of $17.82 and a 12 month high of $27.80. The company has a fifty day simple moving average of $20.96 and a 200 day simple moving average of $21.09.

Kenvue (NYSE:KVUEGet Free Report) last released its earnings results on Thursday, February 8th. The company reported $0.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.28 by $0.03. The firm had revenue of $3.67 billion during the quarter, compared to analysts’ expectations of $3.78 billion. Kenvue had a return on equity of 14.83% and a net margin of 9.87%. The business’s revenue for the quarter was down 2.7% on a year-over-year basis. On average, analysts predict that Kenvue Inc. will post 1.19 EPS for the current fiscal year.

Kenvue Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, February 28th. Shareholders of record on Wednesday, February 14th will be issued a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 4.14%. The ex-dividend date of this dividend is Tuesday, February 13th.

Kenvue Profile

(Free Report)

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands.

Featured Stories

Institutional Ownership by Quarter for Kenvue (NYSE:KVUE)

Receive News & Ratings for Kenvue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kenvue and related companies with MarketBeat.com's FREE daily email newsletter.